REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>
RNS Number : 3429EHikma Pharmaceuticals Plc08 February 2018Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Said Darwazah
2
Reason for the notification
a)
Position/status
Chairman and Chief Executive Officer / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Chairman and Chief Executive is a director of and shareholder in Darhold Limited with an equity interest of 21.67%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman
Mazen Darwazah
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mazen Darwazah
2
Reason for the notification
a)
Position/status
Executive Vice Chairman / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.92%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman
Mohammed 'Ali' Al-Husry
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mohammed 'Ali' Al-Husry
2
Reason for the notification
a)
Position/status
Non-Executive Director/ PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Release of a pledge by Darhold Limited over 2,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.01%.
c)
Price(s) and volume(s)
Price(s): 0.00p
Volume(s): 2,000,000
d)
Aggregated information
Aggregated volume: 2,000,000
Price: 0.00p
e)
Date of the transaction
7 December 2017
f)
Place of the transaction
Amman
This information is provided by RNSThe company news service from the London Stock ExchangeENDDSHBDGDDIXGBGII
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement